Health Care & Life Sciences » Pharmaceuticals | Medipal Holdings Corp.

Medipal Holdings Corp. | Ownership

Companies that own Medipal Holdings Corp.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
BlackRock Fund Advisors
5,730,332
2.34%
5,730,332
0.01%
01/15/2018
The Vanguard Group, Inc.
3,836,751
1.57%
28,400
0%
07/31/2018
Nomura Asset Management Co., Ltd.
3,689,896
1.51%
87,286
0.04%
07/31/2018
BlackRock Japan Co., Ltd.
3,464,300
1.42%
3,464,300
0.09%
01/15/2018
Silchester International Investors LLP
3,152,000
1.29%
3,152,000
0.31%
09/30/2017
Daiwa Asset Management Co. Ltd.
1,777,700
0.73%
15,202
0.04%
07/31/2018
Nikko Asset Management Co., Ltd.
1,560,700
0.64%
-5,399
0.02%
09/03/2018
Morant Wright Management Ltd.
1,540,000
0.63%
280,000
1.6%
09/29/2017
Norges Bank Investment Management
1,397,599
0.56%
-1,488,889
0%
12/31/2017
Deutsche Asset Management (UK) Ltd. (Investment Management)
1,351,018
0.55%
-1,000
0.05%
09/06/2018

About Medipal Holdings

View Profile
Address
2-7-15 Yaesu
Tokyo Tokyo 104
Japan
Employees -
Website http://www.medipal.co.jp
Updated 07/08/2019
Medipal Holdings Corp. manages its group companies which are engaged in the sale of pharmaceuticals, cosmetics, and daily necessities. Its operations are carried out through the following segments: Prescription Pharmaceutical Wholesale Business; Cosmetics, Daily Necessities, and Over-The-Counter (OTC) Pharmaceutical Wholesale Business; and Animal Health Products Wholesale Business. The Prescription Pharmaceutical Wholesale Business segment conducts wholesale business for hospitals, clinics, and dispensing pharmacies.